Fri, Aug 29, 2014, 6:16 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

BioLife Solutions, Inc. Message Board

  • hwmccusker hwmccusker Dec 12, 2012 8:32 AM Flag

    HypoThermosol® P1 Clinical Trial

    The Bottom Line: HypoThermosol allows TIG to increase the stability profile of its clinical cell-based products and extend their shelf-life … the key in the commercial distribution. I have continually … touted BLFS as a “BUY” opportunity. It has enjoyed its recent joys of growth spurts and its sorrow in profit taking by day trader and investors – a market made timing for traders. BLFS closed at $0.30 in a day’s range of $0.30 to $0.30 with only 600 share volume. I continue to reiterate this as a “BUY” on downdraft … still sticking to BLFS being under-valued –with a target of $0.50 by years end since the stock has already visited $0.45 on 11/23/12. I could foresee a $0.05 to $0.10 rise based on the thinly traded activity of the stock many times without a news stimulus.

    Sentiment: Buy

2.37+0.03(+1.33%)Aug 29 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.